Prevention & lipidsCross-sectional study

Differential Associations of Cigar, Pipe, and Smokeless Tobacco Use Versus Combustible Cigarette Use With Subclinical Markers of Inflammation, Thrombosis, and Atherosclerosis: The Cross-Cohort Collaboration–Tobacco Working Group

CirculationPublished

  • Cross-sectional study
  • pooled multicohort data

Authors' conclusion

Use of noncigarette tobacco products is linked to subclinical markers related to cardiovascular harm.

Study context

Population
Participants of the Cross-Cohort Collaboration-Tobacco data set
Participants
98,450 participants
Exposure
Current cigar, pipe or smokeless tobacco use vs never use; current cigarette use vs never cigarette use
Outcome
Subclinical markers: hs-CRP, interleukin-6, fibrinogen, D-dimer, CAC, carotid intima-media thickness, carotid plaque, ankle-brachial index

Main finding

As reported in the abstract

High-sensitivity C-reactive protein (geometric mean scale)

% higher

Cigar (current) vs Reference
10% (95% CI 1–20)
Cigar (sole) vs Reference
19% (95% CI 12–26)
Cigar (exclusive) vs Reference
11% (95% CI 2–21)

Observational data: associations, not effects.

Further findings

OutcomeValues% higher (95% CI)
Interleukin-615% (6–24)
Prevalence of current useCigarette 20.0% · Cigar 3.0% · Pipe 0.8% · Smokeless tobacco 1.5%
Interleukin-6 — Current, sole and exclusive pipe use: 22% to 32% higher levels
all P values <0.05

Fibrinogen

2% to 6% higher among sole users of cigars, pipes and smokeless tobacco
all P values <0.05

Carotid plaque and carotid intima-media thickness

Noncigarette tobacco use moderately associated

Original publication

Differential Associations of Cigar, Pipe, and Smokeless Tobacco Use Versus Combustible Cigarette Use With Subclinical Markers of Inflammation, Thrombosis, and Atherosclerosis: The Cross-Cohort Collaboration–Tobacco Working Group. Circulation. Published 27 January 2025. doi:10.1161/circulationaha.124.070852

Summarised from the published abstract; every number is checked against it